BioAge Labs Director Michael H. Davidson Receives 22,000 Stock Options

This Form 4 filing reports that Michael H. Davidson, a director of BioAge Labs, Inc. (ticker: BIOA), was granted 22,000 stock options on June 10, 2026. The options have an exercise price of $15.48 per share and expire on June 9, 2036. The entire option award vests on the earlier of either the date of the next annual meeting of the company's stockholders or the one-year anniversary of the grant date, subject to Davidson's continued service to the company on the applicable vesting date. The transaction was reported on June 12, 2026, and was signed by Dov A. Goldstein as attorney-in-fact. This represents a standard equity compensation award to a director, with the options granted at fair market value and subject to time-based vesting conditions.